An ongoing extension study following participants already enrolled in earlier phases of CSU treatment research.
This long-term extension study follows participants who completed earlier phases of CSU treatment research, evaluating the safety, tolerability, and durability of treatment effect over an extended period. Enrollment is currently closed and we are not accepting new participants. Currently enrolled participants continue to be followed by our research team.
We are no longer accepting new participants for this study.
Existing participants continue with scheduled study visits.
Contact us to hear about upcoming CSU studies.
An injectable biologic medication targeting IgE-mediated pathways involved in chronic urticaria.
All participants in this extension phase receive the active study medicine.
Currently enrolling instead: CSU clinical trial, Food allergy study. You can also call 437-317-1991 or email researchinfo@allergycentre.ca to hear about upcoming studies.
See enrolling studies